A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

NCT02757768 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

715

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia
Overactive Bladder

Interventions

DRUG: Mirabegron
DRUG: Placebo
DRUG: Tamsulosin Hydrochloride

Sponsor

Astellas Pharma Global Development, Inc.